# Pharmaceutical companies sponsoring Formula 1 teams

> Developing situation record from CLSTR: https://clstr.news/situations/pharmaceutical-companies-sponsoring-formula-1-teams
> Updated: 2026-11-17T06:30:00.000Z. Sources: 2. Developments: 2.

Pharmaceutical companies have entered into multi-year agreements to partner with Formula 1 teams. 

In October 2026, AbbVie announced it would become the official pharmaceutical partner of the McLaren Mastercard Formula 1 team. Through its ‘Race to Innovate’ program, AbbVie committed to donating $10,000 for every 10 points McLaren earns in the Constructors' Championship to support charities and patient advocacy groups for autoimmune and immune-mediated diseases. This partnership was scheduled to debut at the United States Grand Prix.

In November 2026, Viatris Inc. announced a multi-year agreement to become the official global pharmaceutical partner of the Cadillac Formula 1 Team. This collaboration is set to begin with the 2027 Formula 1 season, aiming to increase brand visibility for Viatris while expanding the commercial ecosystem for the Cadillac team as it prepares for its 2026 debut.

## Timeline

### 2026-11-17: Viatris named official global pharmaceutical partner of Cadillac F1 Team

Viatris Inc. has signed a multi-year deal to become the official global pharmaceutical partner of the Cadillac Formula 1 Team, starting in 2027.

2 sources. https://clstr.news/cluster/viatris-named-official-global-pharmaceutical-partner-of-cadillac-f1-team

### 2026-10-20: AbbVie and McLaren announce Formula 1 partnership

AbbVie has signed a multi-year deal to become the official pharmaceutical partner of the McLaren Formula 1 team, pledging donations to autoimmune disease charities based on team performance.

2 sources. https://clstr.news/cluster/abbvie-and-mclaren-announce-formula-1-partnership

---
Cite as: Pharmaceutical companies sponsoring Formula 1 teams. CLSTR, https://clstr.news/situations/pharmaceutical-companies-sponsoring-formula-1-teams
